Health

Rwanda set to venture into cancer research

Rwanda could soon be one of the first countries in Africa to engage in clinical trials and research for cancer. The project is also likely to target other diagnostic diseases. The good news was revealed by the Ministry of Health during a three-day exploratory visit by Robert Mulroy, the CEO of Merrimack Pharmaceuticals, a biopharmaceutical company involved in developing and preparing innovative medicines for the treatment of deadly diseases such as cancer. During his visit, Mulroy was impressed mainly by the cancer centre at Butaro.
no image
Solomon Asaba